Clinical Trial Update: Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI) [NA]

View source ↗

Summary

The TARGET-PCI trial investigating thrombocyte activity reassessment and genotyping in coronary artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: LifeBridge Health | Conditions: Coronary Artery Disease | NA | Status: TERMINATED